Buntanetap (formerly known as posiphen) is an orally-administered small molecule translational inhibitor of aggregating neurotoxic proteins that is under investigation for the treatment of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.